These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

798 related items for PubMed ID: 16405235

  • 1. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
    Todorović-Tirnanić M, Obradović V, Rolović Z, Suvajdzić N, Elezović I, Colović M, Pavlović S, Bosnjaković V.
    Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura?
    Navez J, Hubert C, Gigot JF, Navez B, Lambert C, Jamar F, Danse E, Lannoy V, Jabbour N.
    Platelets; 2015; 26(6):573-6. PubMed ID: 25275667
    [Abstract] [Full Text] [Related]

  • 4. The sequestration of 111-In-labelled autologous platelets and the efficiency of splenectomy.
    Najean Y, Rain JD, Dufour V.
    Nouv Rev Fr Hematol (1978); 1991; 33(6):449-50. PubMed ID: 1818297
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of splenectomy on immune thrombocytopenic purpura in (NZW x BXSB) F1 mice: analyses of platelet kinetics and anti-platelet antibody production.
    Mizutani H, Furubayashi T, Kashiwagi H, Honda S, Take H, Kurata Y, Yonezawa T, Tarui S, Ikehara S.
    Thromb Haemost; 1992 May 04; 67(5):563-6. PubMed ID: 1519215
    [Abstract] [Full Text] [Related]

  • 8. Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry.
    Sarpatwari A, Provan D, Erqou S, Sobnack R, David Tai FW, Newland AC.
    Br J Haematol; 2010 Dec 04; 151(5):477-87. PubMed ID: 20950403
    [Abstract] [Full Text] [Related]

  • 9. The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction.
    Peters AM, Saverymuttu SH, Wonke B, Lewis SM, Lavender JP.
    Br J Haematol; 1984 Aug 04; 57(4):637-49. PubMed ID: 6430336
    [Abstract] [Full Text] [Related]

  • 10. Determining the lifespan of platelets labelled with 111In oxinate--first results.
    Todorović-Tirnanić M, Rolović Z, Obradović V, Bosnjaković V.
    Med Pregl; 1993 Aug 04; 46 Suppl 1():97-9. PubMed ID: 8569625
    [Abstract] [Full Text] [Related]

  • 11. 111In-platelets dynamic study in chronic immune thrombocytopenic purpura.
    Todorović-Tirnanić MV, Obradović VB, Pavlović SV, Suvajdzić ND, Elezović IV, Colović MD, Bosnjaković VB.
    Nucl Med Rev Cent East Eur; 2002 Aug 04; 5(2):121-5. PubMed ID: 14600870
    [Abstract] [Full Text] [Related]

  • 12. Autologous platelet kinetics in patients with severe thrombocytopenia: discrimination between disorders of production and destruction.
    Tomer A, Hanson SR, Harker LA.
    J Lab Clin Med; 1991 Dec 04; 118(6):546-54. PubMed ID: 1744503
    [Abstract] [Full Text] [Related]

  • 13. The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies.
    Najean Y, Rain JD, Billotey C.
    Br J Haematol; 1997 Jun 04; 97(3):547-50. PubMed ID: 9207397
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M, Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto.
    Haematologica; 2005 Jan 04; 90(1):72-7. PubMed ID: 15642672
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr 04; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.